Glenmark pharma share price moneycontrol
Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture and marketing of pharmaceutical products. It operates through the following segments: India, United States, Latin America, Europe, and Rest of the World. GLENMARK PHARMA: Get the latest GLENMARK PHARMA Share price and stock price updates, live NSE/BSE share price, share market reports, financial report, balance sheet, price charts, financial forecast news and quotes only at Equitymaster.com Share market update: BSE Midcap index dips; Glenmark Pharma slumps 5% The S&P BSE MidCap index was trading 0.89 per cent down at 15,554.74. Historical index on Bombay Stock Exchange : E-"Should I invest in Glenmark Pharmaceuticals stock?" "Should I trade "GLENMARK" stock today?" According to our live Forecast System, Glenmark Pharmaceuticals Ltd stock is a bad long-term (1-year) investment*. "Glenmark Pharmaceuticals Ltd" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis.
Glenmark Pharmaceuticals Ltd Stock Price (209.60) - Check here Glenmark Pharmaceuticals Ltd share price today live, Glenmark Pharmaceuticals Ltd stock price, Glenmark Pharmaceuticals Ltd NSE/BSE
Glenmark Share Price, Glenmark Stock Price, Glenmark Pharma Ltd. Stock/Share prices, Glenmark Pharma Ltd. Live BSE/NSE, F&O Quote of Glenmark Pharma Instrument, Authorized Capital, Issued Capital, - P A I D U P -. FromTo, (Rs. cr), ( Rs. cr), Shares (nos), Face Value, Capital Get Live Glenmark Pharma stock market chart. Free Glenmark NSE / BSE. Get Glenmark Pharma detailed stock quotes and technical charts for Glenmark. Track Glenmark on the go with the moneycontrol app Historic Prices of Glenmark. Moneycontrol Technical Chart Analysis of Glenmark, BSE/NSE Market chart Glenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 5821.13 Crore) operating in Pharmaceuticals
Historical index on Bombay Stock Exchange : E-"Should I invest in Glenmark Pharmaceuticals stock?" "Should I trade "GLENMARK" stock today?" According to our live Forecast System, Glenmark Pharmaceuticals Ltd stock is a bad long-term (1-year) investment*. "Glenmark Pharmaceuticals Ltd" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis.
MoneyControl; Feb 14, 2020 10:46. © Reuters. sizes= Glenmark Pharma sells gynaecology business, share price gains. The share touched its 52-week high
Glenmark Pharmaceuticals Ltd Stock Price (209.60) - Check here Glenmark Pharmaceuticals Ltd share price today live, Glenmark Pharmaceuticals Ltd stock price, Glenmark Pharmaceuticals Ltd NSE/BSE
Glenmark inks licensing pact with Hikma for commercialisation of nasal spray Ryaltris in US. Moneycontrol. The licensing pact for Ryaltris has been signed Why GLENMARK shares are falling or up today? Glenmark Pharmaceuticals Ltd. You can also check GLENMARK share price target recommended by brokerages. https://www.moneycontrol.com/news/business/markets/broker reply. For the year ending June 2019 Glenmark Pharma has declared an equity dividend of 200.00% amounting to Rs 2 per share. At the current share price of Rs 368.90 this results in a dividend yield of 0.54%. Get Live Glenmark Pharma stock market chart. Free Glenmark Historic stock charts for NSE / BSE. Get Glenmark Pharma detailed stock quotes and technical charts for Glenmark. Moneycontrol Technical Chart Analysis of Glenmark, BSE/NSE Market chart analysis,live market index & techical information with graph in advance features. Glenmark Pharma share price jumped over 22 percent on November 18 after global research firm CLSA had upgraded the stocks to buy from sell and raised target to Rs 410 from Rs 350 per share Get Glenmark Pharmaceuticals Ltd. live share price, historical charts, volume, market capitalisation, market performance, reports and other company details.
MoneyControl; Feb 14, 2020 10:46. © Reuters. sizes= Glenmark Pharma sells gynaecology business, share price gains. The share touched its 52-week high
Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 6072.35 Crore to Sales Value (96.31 % of Total Sales), Other Operating Revenue which contributed Rs 173.73 Crore to Sales Value (2.75 % of Total Sales) and Sale of services which contributed Rs 58.79 Crore to Sales Value (0.93 % of Total Sales)for the year ending 31-Mar-2019. For the year ending March 2019, Glenmark Pharma has declared an equity dividend of 200.00% amounting to Rs 2 per share. At the current share price of Rs 384.60 this results in a dividend yield of 0.52%. The company has a good dividend track report and has consistently declared dividends for the last 5 years. GLENMARK PHARMA Share Price Today: GLENMARK PHARMA last traded price had tanked 5.4% to Rs 205.8 on the BSE. On the NSE, GLENMARK PHARMA last traded price had tanked 5.9% to Rs 205.0. The total volume of shares traded was 3.9 m. Overall, the broader S&P BSE HEALTHCARE Index was down by 0.0%. And the benchmark S&P BSE SENSEX was at 30,579.1 (down 2.6%). Glenmark Q3 net profit rises 64% to Rs 190.83 cr; to raise $400 mn. Feb 11, 19:48. Glenmark board to consider fund raising options on February 14. Jan 22, 11:45. Glenmark Pharma sells gynaecology business, share price gains Get Glenmark Pharmaceuticals Ltd. live share price, historical charts, volume, market capitalisation, market performance, reports and other company details. Glenmark Pharmaceuticals Ltd Stock Price (209.60) - Check here Glenmark Pharmaceuticals Ltd share price today live, Glenmark Pharmaceuticals Ltd stock price, Glenmark Pharmaceuticals Ltd NSE/BSE
Glenmark Pharma share price jumped over 22 percent on November 18 after global research firm CLSA had upgraded the stocks to buy from sell and raised target to Rs 410 from Rs 350 per share Get Glenmark Pharmaceuticals Ltd. live share price, historical charts, volume, market capitalisation, market performance, reports and other company details. Get Live BSE/ NSE share price of Glenmark Pharma. View Glenmark Pharma historical charts, stock market reports, financial report, volume, market performance & latest news on NDTV Profit. Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 6072.35 Crore to Sales Value (96.31 % of Total Sales), Other Operating Revenue which contributed Rs 173.73 Crore to Sales Value (2.75 % of Total Sales) and Sale of services which contributed Rs 58.79 Crore to Sales Value (0.93 % of Total Sales)for the year ending 31-Mar-2019.